Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population

Alison J Rodger, Rebecca Lodwick, Mauro Schechter, Steven Deeks, Janaki Amin, Richard Gilson, Roger Paredes, Elzbieta Bakowska, Frederik N Engsig, Andrew Phillips, INSIGHT SMART, ESPRIT Study Groups, M. Ristola

Research output: Contribution to journalJournal articleResearchpeer-review

296 Citations (Scopus)

Abstract

Due to the success of antiretroviral therapy (ART), it is relevant to ask whether death rates in optimally treated HIV are higher than the general population. The objective was to compare mortality rates in well controlled HIV-infected adults in the SMART and ESPRIT clinical trials with the general population.
Original languageEnglish
JournalAIDS
Volume27
Issue number6
Pages (from-to)973-9
Number of pages7
ISSN0269-9370
DOIs
Publication statusPublished - 27 Mar 2013

Keywords

  • Adult
  • Anti-HIV Agents
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Female
  • HIV Infections
  • Humans
  • Male
  • Middle Aged
  • Survival Analysis
  • Treatment Outcome
  • Viral Load

Fingerprint

Dive into the research topics of 'Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population'. Together they form a unique fingerprint.

Cite this